Announcement on the Resolution of the 10th Board of Directors of the 10th Session
Release time:
2020-08-05
证券代码:600668 证券简称:尖峰集团 编号:临2019-008
债券简称:13尖峰02 债券代码:122344
浙江尖峰集团股份有限公司
十届10次董事会决议公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
一、董事会会议召开情况
(一)本次董事会会议的召集、召开符合有关法律、法规及公司《章程》的相关规定。
(二)2019年4月15日,公司以传真、电子邮件及专人送达的方式发出了本次董事会会议通知。
(三)2019年4月26日,本次董事会会议在浙江省金华市尖峰大厦三楼会议室以现场表决的方式召开。
(四)公司现有九名董事,全体董事出席了会议,其中:八名董事亲自参加了会议,杜自弘董事委托董事长蒋晓萌先生代为出席会议并表决。
(五)本次董事会由董事长蒋晓萌主持,公司监事和高级管理人员列席会议。
二、董事会会议审议情况
1、通过了2018年度总经理业务报告
董事会审议并通过了该报告。
表决结果:同意9票、反对0票、弃权0票。
2、通过了2018年度财务决算报告
董事会审议并通过了该报告。
表决结果:同意9票、反对0票、弃权0票。
本报告需提交股东大会审议
3、通过了2018年度利润分配预案
董事会审议并通过了该预案。
公司2018年度拟进行现金分配,以2018年末股本344,083,828股为基数,每10股派发现金红利3.0元(含税),向股权登记日登记在册的全体股东派发现金股利总额为103,225,148.40元(含税)。2018年度不进行公积金转增股本。
表决结果:同意9票、反对0票、弃权0票。
本预案将提交股东大会审议。
详见《关于2018年度利润分配预案的公告》(临2019-015)。
4、通过了聘请公司2019年度审计机构的议案
董事会审议并通过了该议案。同意继续聘请天健会计师事务所(特殊普通合伙)为公司2019年度财务及内部控制审计机构。
表决结果:同意9票、反对0票、弃权0票。
该议案将提交股东大会审议。
5、通过了为控股子公司提供担保的议案
董事会审议并通过了该议案。
对控股子公司的融资及担保,设定如下额度:
|
被担保单位 |
额度(万元) |
|
浙江尖峰药业有限公司 |
30000 |
|
上海北卡医药技术有限公司及其全资子公司 |
20000 |
|
贵州黄平谷陇铭川水泥有限公司 |
30000 |
|
浙江尖峰国际贸易有限公司 |
8000 |
|
合计 |
88000 |
同意上海北卡根据实际经营情况与其下属各全资子公司共同使用上述额度。
2、尖峰国贸是大连商品交易所的指定交割仓库,根据大连商品交易所的要求,需要本公司提供保函,对所存放的期货货物提供担保。另外,为了拓展业务,尖峰国贸目前正在申请郑州商品交易所以及上海期货交易所的交割仓库资质,也需要本公司为其提供担保。为了尖峰国贸顺利开展期货交割仓库业务,拟同意为尖峰国贸出具保函,对存放在尖峰国贸的期货货物提供担保。
在设定额度内的金融机构借款及担保事宜均授权本公司董事长决定执行。
表决结果:同意9票、反对0票、弃权0票。
详见《关于为控股子公司提供担保的公告》(临2019-010)。
本议案需提交股东大会审议。
6、通过了公司会计政策变更的议案
董事会审议并通过了该议案。
表决结果:同意9票、反对0票、弃权0票。
详见《关于公司会计政策变更的公告》(临2019-018)。
7、通过了2018年年度报告及其摘要
董事会审议并通过了该报告。
表决结果:同意9票、反对0票、弃权0票。
2018年度报告全文及摘要详见上海证券交易所网站(www.sse.com.cn)。
该报告需提交股东大会审议。
8、通过了2019年第一季度报告
董事会审议并通过了该报告。
表决结果:同意9票、反对0票、弃权0票。
2019年第一季度报告详见上海证券交易所网站(www.sse.com.cn)。
9、关于公司2019年度日常关联交易的议案
董事会审议并通过了该议案。
表决结果:同意6票、反对0票、弃权0票。关联董事蒋晓萌、杜自弘、虞建红回避了该议案的表决。
详见《关于公司2019年度日常关联交易的公告》(临2019-011)。
10、通过了授权董事长利用自有资金进行委托理财的议案
董事会审议并通过了该议案。授权董事长行使不超过人民币5亿元的委托理财的决策权,在该额度内资金可以滚动使用,但任一时点存续的委托理财余额合计不得超过5亿元。每笔委托理财的期限不得超过12个月。授权期限自公司本次董事会审议通过之日起3年内有效。
表决结果:同意9票、反对0票、弃权0票。
详见《关于授权公司董事长利用自有资金进行委托理财的公告》(临2019-012)。
11、通过了召开2018年度股东大会的议案
董事会审议并通过了该议案。董事会决定于2019年5月24日在浙江省金华市婺江东路88号尖峰大厦召开2018年度股东大会,并提供网络表决方式。
表决结果:同意9票、反对0票、弃权0票
详见《关于召开2018年度股东大会的通知》(临2019-017)。
12、通过了公司《章程》修订案
董事会审议并通过了该修订案。
表决结果:同意9票、反对0票、弃权0票。
详见关于修订公司《章程》的公告(临2019-014)。
该议案需提交股东大会审议。
13、通过了公司新修订的《股东大会议事规则》
董事会审议并通过了该议案。
表决结果:同意9票、反对0票、弃权0票。
《股东大会议事规则》详见上海证券交易所网站(www.sse.com.cn)。
该议案需提交股东大会审议。
14、通过了公司新修订的《董事会议事规则》
董事会审议并通过了该议案。
表决结果:同意9票、反对0票、弃权0票。
《董事会议事规则》详见上海证券交易所网站(www.sse.com.cn)。
该议案需提交股东大会审议。
15、通过了尖峰药业增资的关联交易议案
董事会审议并通过了该议案。
表决结果:同意7票、反对0票、弃权0票。关联董事蒋晓萌、刘波回避了该议案的表决。
详见《关于尖峰药业增资的关联交易公告》(临2019-013)。
16、通过了安徽众望增资和二期技改项目的议案
董事会审议并通过了该议案。
本公司控股子公司浙江尖峰药业有限公司的控股子公司上海北卡医药技术有限公司(以下简称:上海北卡)拟出资6000万元对其全资子公司安徽众望制药有限公司(以下简称:安徽众望)进行增资。增资完成后,安徽众望注册资本由原来的4000万元增加至10000万元,上海北卡仍持有100%股权。
安徽众望拟实施二期技改项目,项目总投资17500万元。具体建设内容为:生产车间三、生产车间五、生产车间六、办公楼、研发质检楼、综合仓库一、储罐区(含泵区);新增建设用地约82亩,并对现有二车间设备设施进行局部技改。
表决结果:同意9票、反对0票、弃权0票。
17、通过了2018年度内部控制评价报告
董事会审议并通过了该报告。
表决结果:同意9票、反对0票、弃权0票。
18、通过了战略规划纲要(2019-2023)
董事会审议并通过了该议案。
表决结果:同意9票、反对0票、弃权0票。
《战略规划纲要(2019-2023)》详见上海证券交易所网站(www.sse.com.cn)。
该议案需提交股东大会审议。
19、通过了2018年度《中长期激励基金计提方案》
董事会审议并通过了该议案。根据公司《中长期激励管理办法》的规定,2018年度提取中长期激励基金3475.03万元。
表决结果:同意9票、反对0票、弃权0票。
20、通过了董事会审计委员会2018年度履职报告
董事会审议并通过了该报告。
表决结果:同意9票、反对0票、弃权0票
21、通过了独立董事2018年度述职报告
董事会审议并通过了该报告。
表决结果:同意9票、反对0票、弃权0票
独立董事将向股东大会报告。
22、通过了2018年度董事会工作报告
董事会审议并通过了该报告。
表决结果:同意9票、反对0票、弃权0票。
该报告将提交股东大会审议。
公司独立董事的其他独立意见:
此外,公司独立董事对上述4(关于聘请公司2019年度审计机构的议案)、5(关于为控股子公司提供担保的议案)、6(关于公司会计政策变更的议案)、9(关于公司2019年度日常关联交易的议案)、10(关于授权董事长利用自有资金进行委托理财的议案)、15(关于尖峰药业增资的关联交易议案)、19(关于2018年度《中长期激励基金计提方案》)七项决议都发表了同意的独立意见,认为:上述董事会决议的形成符合《公司法》、公司《章程》等有关规定,没有损害中小股东的利益。
三、相关附件
1、公司第十届董事会第10次会议决议
2、公司独立董事对上述相关事项的独立董事意见
特此公告
浙江尖峰集团股份有限公司
董事会
二〇一九年四月三十日
More information
Teachers and Students of Zhejiang Gongshang University Visit Peak Health
News from our newspaper On the morning of June 9, a group of 18 teachers and students from Zhejiang Gongshang University came to Jianfeng Health for a visit and discussion, and conducted research on the establishment of Zhejiang Gongshang University Food Industrialization Research Institute in Jinhua. The leader of this visit is Professor Song Guanglei from the School of Food and Biological Engineering, Zhejiang Gongshang University. The teachers and students are mainly from the School of Food and Engineering, specializing in food science, food safety, biochemical and biotechnology, focusing on extraction and separation, functional activity and The research of functional food, in addition to the professor of the Department of E-commerce of the School of Management Engineering and E-commerce. Chen Daiyou, general manager of Jianfeng Health, Li Wende, deputy general manager, and relevant personnel from R & D, quality management, administrative personnel and other departments attended the forum. Li Wende introduced the basic situation, technical production level, scientific and technological research and development characteristics of Jianfeng Health Company in the form of PPT, as well as the relevant policies of Jinhua Municipal Government on talent introduction. Chen Daiyou focused on the development vision of Jianfeng Health Technology and the construction of scientific and technological talents, and welcomed graduate students from the Industrial and Commercial University to join the team of Jianfeng Health after graduation. Professor Song Guanglei fully affirmed the software and hardware facilities and humanistic management of Jianfeng Health Company. He said that most of the teachers and students who came to visit this time were professional in line with the industry of Jianfeng Health Company. The two sides could carry out in-depth cooperation in product development, technology upgrading and talent reserve. Fourteen graduate students also introduced their respective situations and study and research directions. After the symposium, the teachers and students visited the health company's testing center, R & D laboratory and plant extraction workshop with great interest.
2020
07-31
Trial operation of large pharmacy micro-mall
The construction of the micro-mall of Jianfeng Pharmacy is basically ready at present. On June 17, Shuangxi and Donglai chain stores took the lead in the trial operation of the micro-mall. At present, online consumption through computers and mobile phones has become a way of life in China. In particular, various software represented by WeChat covers more than 90% of smart phones, and has many functions such as information exchange and online payment. It is a new type of shopping system based on WeChat platform, using mobile Internet technology to realize the integration of online and offline marketing. At present, there are more than 1000 kinds of commodities on the shelves of the micro-mall of Jianfeng pharmacy, mainly OTC commodities of over-the-counter drugs, which are basically synchronized with pharmacies. Customers only need to pay attention to the public number of Jianfeng Pharmacy and enter the micro-mall to collect coupons through the "online drug purchase" on the public number page. They can find the required drugs on the mobile phone to purchase and pay for them. The delivery method can be delivered to the door or the store can pick them up by itself. The purchase of drugs through the micro-mall is not only convenient and fast, but also can reduce the phenomenon of queuing in the store. According to reports, the opening of the micro mall by the big pharmacy is to expand the new service model and provide more and better extended services to the masses. Prior to this, the WeChat public number of the large pharmacy has already made a useful attempt to push health information, and the operation of the micro-mall will further provide users with new channels for seeking medical advice. While further improving the micro-mall system, the large pharmacy will add "online pharmacists" and other service items to provide users with real-time consulting services such as medication guidance, drug purchase recommendation, health care knowledge and so on in the form of voice or text. (Tang Wenshu)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-30
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
On May 27, the Party Committee of the Group Company held a branch secretary meeting to comprehensively review and summarize the Party building work of the Company in 2016 and sign the responsibility book for the management of Party building work objectives in 2017. At the meeting, Qin xuping, member of the party Committee of the group company and director of the party-mass work department, made a comprehensive summary of the company's party building work in 2016, put forward the 2017 work plan, and conveyed the "key points of party building work in the city's two new organizations in 2017" issued by the two new working committees of Jinhua municipal party Committee, and the spirit of the speech made by the relevant leaders of the municipal party Committee at the recent meeting of the city's two new working committee, this paper explains the "ten questions" of the two new grass-roots party organizations, the "ten questions" of Party members and some problems that need attention in the process of Party member development. Members of the party committee of the group company, secretaries of grass-roots party committees and branch secretaries expressed their views and conducted extensive exchanges on such topics as how to deepen the "two learning and one doing", further play the role of party organizations in the process of enterprise operation and management, and how to do a good job in organizational construction in 2017. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, on behalf of the party committee of the group, signed the 2017 party building work target management responsibility letter with the heads of the party organizations of various professional companies and directly affiliated enterprises. In his speech at the meeting, Jiang Xiaomeng said that the Politburo meeting of the CPC Central Committee held on the 26th reviewed and approved the "Decision on Amending the Regulations on the Inspection Work of the Communist Party of China" and other reports, which is a major measure to further implement the provisions of the party constitution and strengthen internal party supervision. Specific to the internal party building work of the enterprise, all cadres and party members should earnestly study relevant policies and documents, and earnestly understand the spirit of the central government
2020
07-31